CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children

Published: 31. October, 2025

Successful completion of technology transfer of CT001 with STAQ Pharma supporting near term product…

• Successful completion of technology transfer of CT001 with STAQ Pharma supporting near term product availability
• CT001 is expected to reach the first hospitals in the US within the coming months
• The finalisation of marketing and training material is currently in progress

Comments from the CEO, Jes Trygved
“Our collaboration with STAQ Pharma marks an important step in bringing CT001 to patients in the United States. STAQ Pharma’s strong expertise in sterile manufacturing ensures a high-quality product for hospitals, and with marketing and training materials now being finalised, we are excited to soon make CT001 available for children in need of better pain management options.”

Link to Release; STAQ collaboration